Provexis logo

PXS - Provexis Share Price

0.325p 0.0  0.0%

Last Trade - 13/09/19

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £6.45m
Enterprise Value £5.64m
Revenue £322k
Position in Universe 1629th / 1830
Bullish
Bearish
Unlock PXS Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PXS Revenue Unlock PXS Revenue

Net Income

PXS Net Income Unlock PXS Revenue

Normalised EPS

PXS Normalised EPS Unlock PXS Revenue

PE Ratio Range

PXS PE Ratio Range Unlock PXS Revenue

Dividend Yield Range

PXS Dividend Yield Range Unlock PXS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PXS EPS Forecasts Unlock PXS Revenue
Profile Summary

Provexis plc is engaged in developing and licensing the Fruitflow heart-health functional food ingredient for the global functional food sector. Fruitflow is a tomato extract, which inhibits platelet aggregation that causes heart attack, stroke and venous thrombosis. The syrup and powder versions of Fruitflow are used in foods, beverages and supplements. The powder version is used in a range of products, including soft gels, capsules, tablets and stick packs. The Company also offers Fruitflow + Omega-3 dietary supplement product, which is a two-in-one supplement in an easy to take capsule supporting healthy blood flow and normal heart function. Fruitflow + Omega-3 dietary supplement product is available through its e-commerce Website www.fruitflowplus.com. The Company's subsidiaries include Provexis Nutrition Limited, Provexis Natural Products Limited and Provexis (IBD) Limited, which are engaged in providing functional food, medical food and dietary supplement technologies.

Directors
Last Annual March 31st, 2019
Last Interim March 31st, 2019
Incorporated April 15, 2004
Public Since June 24, 2005
No. of Shareholders: n/a
No. of Employees: 4
Sector Consumer Defensives
Industry Food & Tobacco
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 1,983,988,174
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PXS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PXS
Upcoming Events for PXS
Similar to PXS
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.